Rowlett, J., NW, P. , Jr, & Bardo, M. (1991). Catalepsy produced by striatal microinjections of the D1 dopamine receptor antagonist SCH 23390 in neonatal rats. Pharmacology, Biochemistry, and Behavior, 40(4), 829-34. https://doi.org/10.1016/0091-3057(91)90093-h

Lauderback, C., Harris-White, M., Wang, Y., NW, P. , Jr, Carney, J., & Butterfield, D. Amyloid beta-peptide inhibits Na+-dependent glutamate uptake. Life Sciences, 65(18-19), 1977-81. https://doi.org/10.1016/s0024-3205(99)00459-2 (Original work published 1999)

Butterfield, D., Howard, B., Yatin, S., Koppal, T., Drake, J., Hensley, K., … Carney, J. Elevated oxidative stress in models of normal brain aging and Alzheimer’s disease. Life Sciences, 65(18-19), 1883-92. https://doi.org/10.1016/s0024-3205(99)00442-7 (Original work published 1999)

Harris, M., Wang, Y., NW, P. , Jr, Hensley, K., Butterfield, D., & Carney, J. (1996). Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures. Journal of Neurochemistry, 67(1), 277-86. https://doi.org/10.1046/j.1471-4159.1996.67010277.x

Harris, M., Carney, J., Cole, P., Hensley, K., Howard, B., Martin, L., … Butterfield, D. (1995). beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer’s disease. Neuroreport, 6(14), 1875-9. https://doi.org/10.1097/00001756-199510020-00013 (Original work published 1995)